Terri Lynn Shigle

7PUBLICATIONS
49CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical virologyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 25, 2025
High-Dose Chemotherapy for Multiply or Poor-Risk Relapsed Germ Cell Tumors.

Yago Nieto, John F Ward, Wayne Hofstetter

|Jan 18, 2025
Real-World Experience With Maribavir for Treatment of Refractory or Resistant Cytomegalovirus Infection in Hematopoietic Cell Transplant Recipients and Hematologic Malignancy Patients.

Marilyne Daher, Fareed Khawaja, Amy Spallone

|Jan 13, 2025
Enhancement of High-Dose Chemotherapy and Autologous SCT with the PARP Inhibitor Olaparib for Refractory Lymphoma.

Yago Nieto, Jeremy Ramdial, Benigno Valdez

|Sep 28, 2024
High activity of the new myeloablative regimen of gemcitabine/clofarabine/busulfan for allogeneic transplant for aggressive lymphomas.

Jeremy Ramdial, Ruitao Lin, Peter F Thall

|Aug 23, 2023
Myeloablative fractionated busulfan for allogeneic stem cell transplant in older patients or patients with comorbidities.

Uday R Popat, Oren Pasvolsky, Roland Bassett

|Jul 09, 2020
Letermovir and its role in the prevention of cytomegalovirus infection in seropositive patients receiving an allogeneic hematopoietic cell transplant.

Terri Lynn Shigle, Victoria Wehr Handy, Roy F Chemaly

Pageof 2

Frequent Collaborators

4 joint publications

Jeremy Ramdial

4 joint publications

Richard E Champlin

4 joint publications

Uday R Popat

3 joint publications

Muzaffar Qazilbash